Artificial Intelligence-based Efficacy Prediction of Phase 3 Clinical Trial for Repurposing Heart Failure Therapies.

Zong, Nansu; Chowdhury, Shaika; Zhou, Shibo; Rajaganapathy, Sivaraman; Yu, Yue; Wang, Liewei; Dai, Qiying; Bielinski, Suzette J; Chen, Yongbin; Cerhan, James R

Zong, Nansu; Chowdhury, Shaika; Zhou, Shibo; Rajaganapathy, Sivaraman; Yu, Yue; Wang, Liewei; Dai, Qiying; Bielinski, Suzette J; Chen, Yongbin; Cerhan, James R.

Afiliação

Zong N; Department of Artificial Intelligence and Informatics Research, Mayo Clinic, Rochester, MN, USA.
Chowdhury S; Department of Artificial Intelligence and Informatics Research, Mayo Clinic, Rochester, MN, USA.
Zhou S; Department of Artificial Intelligence and Informatics Research, Mayo Clinic, Rochester, MN, USA.
Rajaganapathy S; Department of Artificial Intelligence and Informatics Research, Mayo Clinic, Rochester, MN, USA.
Yu Y; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Wang L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
Dai Q; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Bielinski SJ; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Chen Y; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
Cerhan JR; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.

medRxiv ; 2023 Jun 03.

Article em En | MEDLINE | ID: mdl-37398384

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google